Items where Author is "Pardo Llorente, M. D. C."
Article
Bolou, A., Drymoussi, Z., Lanz, D. , Amaefule, C. E., Gonzalez Carreras, Fr. J., Pardo Llorente, M. D. C., Dodds, J., Pizzo, E., Thomas, A., Heighway, J., Harden, A. 
ORCID: 0000-0002-8621-5066, Sanghi, A., Hitman, G., Zamora, J., Pérez, T., Huda, M. S. B. & Thangaratinam, S. (2023).
Metformin in the prevention of type 2 diabetes after gestational diabetes in postnatal women (OMAhA): a UK multicentre randomised, placebo-controlled, double-blind feasibility trial with nested qualitative study.
BMJ Open, 13(11),
article number e073813.
doi: 10.1136/bmjopen-2023-073813
Amaefule, C. E., Bolou, A., Drymoussi, Z. , Gonzalez Carreras, F. J., Pardo Llorente, M. D. C., Lanz, D., Dodds, J., Sweeney, L., Pizzo, E., D'Amico, M., Thomas, A., Heighway, J., Daru, J., Sobhy, S., Robson, J., Sanghi, A., Zamora, J., Harden, A. ORCID: 0000-0002-8621-5066, Hitman, G., Khan, K., Pérez, T., Huda, M. S. B. & Thangaratinam, S. (2020).
Effectiveness and acceptability of metformin in preventing the onset of type 2 diabetes after gestational diabetes in postnatal women: a protocol for a randomised, placebo-controlled, double-blind feasibility trial—Optimising health outcomes with Metformin to prevent diAbetes After pregnancy (OMAhA).
BMJ Open, 10(5),
article number e036198.
doi: 10.1136/bmjopen-2019-036198